Chidamide: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Chidamide

• A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
  NCT05890287 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
  NCT05983107 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer
  NCT06951997 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer
  NCT06685276 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Chidamide?

4 recruiting trials across 8 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.